| PERIOD ENDING | 31-Dec-08 | 30-Nov-07 |
| Total Revenue | 3 |
-
|
| Cost of Revenue |
-
|
-
|
|
| Gross Profit | 3 |
-
|
|
| Operating Expenses |
| Research Development |
-
|
-
|
| Selling General and Administrative | 353 | 78 |
| Non Recurring |
-
|
-
|
| Others | 5 |
-
|
| |
| Total Operating Expenses |
-
|
-
|
|
|
| Operating Income or Loss | (355) | (78) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 23 | 1 |
| Earnings Before Interest And Taxes | (332) | (77) |
| Interest Expense | 1 |
-
|
| Income Before Tax | (332) | (77) |
| Income Tax Expense |
-
|
-
|
| Minority Interest |
-
|
-
|
| |
| Net Income From Continuing Ops | (332) | (77) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
| Extraordinary Items |
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
| Other Items |
-
|
-
|
|
|
| Net Income | (332) | (77) |
| Preferred Stock And Other Adjustments |
-
|
-
|
|
| Net Income Applicable To Common Shares | ($332) | ($77) |
0.10% Nasdaq 0.00%
Income Statement
